Skip to main content

Advertisement

Log in

EEC directives and guidelines applicable to radiopharmaceuticals — 1993

Status quo with particular emphasis on the registration of radiopharmaceuticals which were on the market prior to January 1992

  • Occasional Survey
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

The manufacture, scale and supply of radio-pharmaceuticals in the EEC is regulated by directives that are incorporated into the national laws of the member states. The situation as of 1 January 1993 was not too optimistic, however, as the processing of licensing applications had been completely misjudged. Not one product had been registered as of 1 January. The costs involved are also high and since the European market for radio-pharmaceuticals is relatively small, the market cannot afford this. It would appear that the EEC directives are inadquate and too non-specific, so revision is indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cox, P.H. EEC directives and guidelines applicable to radiopharmaceuticals — 1993. Eur J Nucl Med 20, 712–715 (1993). https://doi.org/10.1007/BF00181764

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00181764

Key words

Navigation